Crossref
journal-article
Wiley
The FASEB Journal (311)
References
47
Referenced
201
10.1016/S0140-6736(97)02073-4
10.1097/00005072-199603000-00001
{'key': 'e_1_2_6_4_1', 'first-page': '879', 'article-title': "Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies", 'volume': '152', 'author': 'Baba M.', 'year': '1998', 'journal-title': 'Am. J. Pathol.'}
/ Am. J. Pathol. / Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies by Baba M. (1998)10.1515/CCLM.2001.047
10.1126/science.275.5300.630
10.1016/S0047-6374(01)00283-4
10.1016/S0021-9258(18)48018-0
/ J. Biol. Chem. / Protein damage and degradation by oxygen radicals. I. general aspects by Davies K. J. (1987)10.1016/S0021-9258(18)48021-0
/ J. Biol. Chem. / Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein by Davies K. J. (1987)10.1007/BF03033137
10.1523/JNEUROSCI.19-04-01484.1999
10.3109/10715769609088005
10.1111/j.1471-4159.1992.tb09437.x
10.1006/bbrc.1994.2428
10.1073/pnas.92.7.2959
10.1016/S0925-4439(00)00034-X
10.1073/pnas.110138997
10.1016/S0014-5793(00)02380-2
{'key': 'e_1_2_6_19_1', 'first-page': '93', 'article-title': 'Brefeldin A inhibits experimentally induced AA amyloidosis', 'volume': '23', 'author': 'Stenstad T.', 'year': '1996', 'journal-title': 'J. Rheumatol.'}
/ J. Rheumatol. / Brefeldin A inhibits experimentally induced AA amyloidosis by Stenstad T. (1996)10.1042/bj3400283
/ Biochem. J. / Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans by Howlett D. R. (1999)10.1074/jbc.M206593200
10.1042/bj3510273
/ Biochem. J. / The molecular interaction of 4'-iodo-4'-deoxydoxorubicin with Leu-55Pro transthyretin ‘amyloid-like’ oligomer leading to disaggregation by Sebastiao M. P. (2000)10.1126/science.1063522
10.1016/S0896-6273(01)00462-7
10.1074/jbc.M109541200
10.1074/jbc.C100551200
10.1016/S0014-5793(03)00367-3
10.1002/bmc.203
10.1002/rcm.498
10.1074/jbc.C100560200
10.1021/bi00164a008
10.1021/bi991447r
10.1074/jbc.M010907200
10.1021/bi020139h
10.1021/bi9904149
10.1038/418291a
/ Nature / Neurodegenerative disease: amyloid pores from pathogenic mutations by Lashuel H. A. (2002)10.1016/S0022-2836(02)01175-0
10.1016/0003-2697(89)90046-8
{'key': 'e_1_2_6_39_1', 'first-page': '633', 'article-title': 'Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones', 'volume': '14', 'author': 'Graham D. G.', 'year': '1978', 'journal-title': 'Mol. Pharmacol.'}
/ Mol. Pharmacol. / Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones by Graham D. G. (1978){'key': 'e_1_2_6_40_1', 'first-page': '503', 'article-title': "Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy", 'volume': '147', 'author': 'Schmidt M. L.', 'year': '1995', 'journal-title': 'Am. J. Pathol.'}
/ Am. J. Pathol. / Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy by Schmidt M. L. (1995){'key': 'e_1_2_6_41_1', 'first-page': '174', 'article-title': 'Forensic neuropathological and immunohistochemical studies on Alzheimer- type dementia (AD/SDAT)', 'volume': '44', 'author': 'Tatsuno Y.', 'year': '1990', 'journal-title': 'Nippon Hoigaku Zasshi'}
/ Nippon Hoigaku Zasshi / Forensic neuropathological and immunohistochemical studies on Alzheimer- type dementia (AD/SDAT) by Tatsuno Y. (1990)10.1006/neur.1996.0025
/ Neurodegeneration / Improved selectivity and sensitivity in the visualization of neurofibrillary tangles, plaques and neuropil threads by Cullen K. M. (1996)10.1523/JNEUROSCI.21-18-07226.2001
10.1021/bi001315u
{'key': 'e_1_2_6_45_1', 'first-page': '183', 'article-title': 'Neuroprotection by dopamine agonists', 'volume': '43', 'author': 'Lange K. W.', 'year': '1994', 'journal-title': 'J. Neural Transm. Suppl.'}
/ J. Neural Transm. Suppl. / Neuroprotection by dopamine agonists by Lange K. W. (1994)10.1111/j.1600-0773.1994.tb00321.x
10.1096/fasebj.12.10.905
10.1007/BF01245973
Dates
Type | When |
---|---|
Created | 21 years, 4 months ago (April 5, 2004, 8:33 p.m.) |
Deposited | 4 years, 1 month ago (July 3, 2021, 6:22 a.m.) |
Indexed | 14 hours, 25 minutes ago (Aug. 30, 2025, 12:26 p.m.) |
Issued | 21 years, 4 months ago (April 1, 2004) |
Published | 21 years, 4 months ago (April 1, 2004) |
Published Online | 21 years, 4 months ago (April 1, 2004) |
Published Print | 21 years, 2 months ago (June 1, 2004) |
Funders
1
National Institutes of Health
10.13039/100000002
Region: Americas
gov (National government)
Labels
3
- Institutos Nacionales de la Salud
- US National Institutes of Health
- NIH
Awards
2
- RO1 NS39985
- RO1 ES10806
@article{Li_2004, title={Dopamine and L‐dopa disaggregate amyloid fibrils: implications for Parkinson’s and Alzheimer’s disease}, volume={18}, ISSN={1530-6860}, url={http://dx.doi.org/10.1096/fj.03-0770fje}, DOI={10.1096/fj.03-0770fje}, number={9}, journal={The FASEB Journal}, publisher={Wiley}, author={Li, Jie and Zhu, Min and Manning-Bog, Amy B. and Di Monte, Donato A. and Fink, Anthony L.}, year={2004}, month=apr, pages={962–964} }